Sign in
4

Changes in Ownership

NORTHWEST BIOTHERAPEUTICS INC Filed Acc 0001104659-20-080808

Options or other derivatives

  • Chief Scientific Officer acquired 3,096,498 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
BOYNTON ALTON L Chief Scientific Officer 2020-07-02 Grant or award · Options to purchase Common Stock, par value $0.001 +605,160 605,160 D
BOYNTON ALTON L Chief Scientific Officer 2020-07-02 Grant or award · Options to purchase Common Stock, par value $0.001 +2,491,338 2,491,338 D
Loading xslF345X03/tm2022243d8_4.xml…